SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16785475
Source:
http://linkedlifedata.com/resource/pubmed/id/16785475
Search
Subject
(
67
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003873
,
umls-concept:C0008976
,
umls-concept:C0030705
,
umls-concept:C0034656
,
umls-concept:C0205177
,
umls-concept:C1280500
,
umls-concept:C1619966
pubmed:issue
12
pubmed:dateCreated
2006-6-20
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00048568
pubmed:abstractText
The selective co-stimulation modulator abatacept demonstrated efficacy for treating rheumatoid arthritis in early clinical studies.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16785475-16785473
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16785475-16785481
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoconjugates
,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
,
http://linkedlifedata.com/resource/pubmed/chemical/abatacept
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1539-3704
pubmed:author
pubmed-author:Abud-MendozaCarlosC
,
pubmed-author:BeckerJean-ClaudeJC
,
pubmed-author:EmeryPaulP
,
pubmed-author:GeZhiyuZ
,
pubmed-author:GenantHarry KHK
,
pubmed-author:KremerJoel MJM
,
pubmed-author:LiTracyT
,
pubmed-author:MorelandLarry WLW
,
pubmed-author:RussellAnthony SAS
,
pubmed-author:SzechinskiJacekJ
,
pubmed-author:WesthovensReneR
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
865-76
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16785475-Adult
,
pubmed-meshheading:16785475-Aged
,
pubmed-meshheading:16785475-Antibody Formation
,
pubmed-meshheading:16785475-Antirheumatic Agents
,
pubmed-meshheading:16785475-Arthritis, Rheumatoid
,
pubmed-meshheading:16785475-Disease Progression
,
pubmed-meshheading:16785475-Double-Blind Method
,
pubmed-meshheading:16785475-Drug Resistance
,
pubmed-meshheading:16785475-Female
,
pubmed-meshheading:16785475-Humans
,
pubmed-meshheading:16785475-Immunoconjugates
,
pubmed-meshheading:16785475-Infection
,
pubmed-meshheading:16785475-Male
,
pubmed-meshheading:16785475-Methotrexate
,
pubmed-meshheading:16785475-Middle Aged
,
pubmed-meshheading:16785475-Quality of Life
,
pubmed-meshheading:16785475-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
pubmed:affiliation
Center for Rheumatology, Albany, New York, USA. jkremer@joint-docs.com
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III